Digestive Health

Available Digestive Health Trials:

• (126-22) Treat-to-Target of Endoscopic Remission in Patients with IBD in Symptomatic Remission: The QUOTIENT Trial

• (150-24) Prevalence of Clonal Hematopoiesis (CH) in Patients with Metabolic associated steatohepatitis (MASH; Formerly Non- Alcoholic Steatohepatitis)

• (249-23) A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Pemvidutide in Non-Cirrhotic Subjects with Nonalcoholic Steatohepatitis (NASH)

• (228-23) A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating The Safety And Efficacy Of Efruxifermin In Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (Nash)/Metabolic Dysfunction-Associated Steatohepatitis (Mash) And Fibrosis

To learn more about available clinical trials, please at 949-764-4577 or clinicalresearch@hoag.org.